Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 12
2004 7
2005 6
2006 9
2007 13
2008 17
2009 16
2010 23
2011 22
2012 14
2013 24
2014 17
2015 16
2016 32
2017 34
2018 34
2019 43
2020 43
2021 65
2022 57
2023 47
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

519 results

Results by year

Filters applied: . Clear all
Page 1
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trial.
Wolff J, Seidel S, Wuelfing P, Lux MP, Zu Eulenburg C, Smollich M, Baumann F, Seitz S, Kuemmel S, Thill M, Tio J, Braun M, Hollaender H, Seitz A, Horn F, Harbeck N, Wuerstlein R. Wolff J, et al. Among authors: harbeck n. Front Oncol. 2024 Apr 18;14:1354377. doi: 10.3389/fonc.2024.1354377. eCollection 2024. Front Oncol. 2024. PMID: 38699636 Free PMC article.
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
Bardia A, Pusztai L, Albain K, Ciruelos EM, Im SA, Hershman D, Kalinsky K, Isaacs C, Loirat D, Testa L, Tokunaga E, Wu J, Dry H, Barlow W, Kozarski R, Maxwell M, Harbeck N, Sharma P. Bardia A, et al. Among authors: harbeck n. Ther Adv Med Oncol. 2024 Apr 29;16:17588359241248336. doi: 10.1177/17588359241248336. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38686016 Free PMC article.
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Goetz MP, Cicin I, Testa L, Tolaney SM, Huober J, Guarneri V, Johnston SRD, Martin M, Rastogi P, Harbeck N, Shahir A, Wei R, André V, Rugo HS, O'Shaughnessy J. Goetz MP, et al. Among authors: harbeck n. NPJ Breast Cancer. 2024 Apr 26;10(1):34. doi: 10.1038/s41523-024-00639-1. NPJ Breast Cancer. 2024. PMID: 38671001 Free PMC article.
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium.
De Schepper M, Koorman T, Richard F, Christgen M, Vincent-Salomon A, Schnitt SJ, van Diest PJ, Zels G, Mertens F, Maetens M, Vanden Bempt I, Harbeck N, Nitz U, Gräser M, Kümmel S, Gluz O, Weynand B, Floris G, Derksen PWB, Desmedt C; Pathology Working Group of the European Lobular Breast Cancer Consortium. De Schepper M, et al. Among authors: harbeck n. Mod Pathol. 2024 Apr 17;37(7):100497. doi: 10.1016/j.modpat.2024.100497. Online ahead of print. Mod Pathol. 2024. PMID: 38641322 Free article.
ABC7 Consensus: Assessment by a German Group of Experts.
Ditsch N, Untch M, Fasching PA, Busch S, Ettl J, Haidinger R, Jackisch C, Lüftner D, Müller L, Müller V, Ruckhäberle E, Schumacher-Wulf E, Thomssen C, Harbeck N, Wuerstlein R. Ditsch N, et al. Among authors: harbeck n. Breast Care (Basel). 2024 Apr;19(2):116-128. doi: 10.1159/000535997. Epub 2024 Jan 24. Breast Care (Basel). 2024. PMID: 38638343
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis.
Gnant M, Abdullah KL, Boyle F, Huang CS, Bickford K, Neunie S, Noble A, Nunn A, Sproat C, Harbeck N, Barrios C. Gnant M, et al. Among authors: harbeck n. JMIR Form Res. 2024 Mar 21;8:e50931. doi: 10.2196/50931. JMIR Form Res. 2024. PMID: 38512328 Free PMC article.
Filgrastim biosimilar (EP2006): A review of 15 years' post-approval evidence.
Gascón P, Harbeck N, Rapoport BL, Anderson R, Brueckmann I, Howe S, Aapro M. Gascón P, et al. Among authors: harbeck n. Crit Rev Oncol Hematol. 2024 Apr;196:104306. doi: 10.1016/j.critrevonc.2024.104306. Epub 2024 Feb 23. Crit Rev Oncol Hematol. 2024. PMID: 38401695 Free article. Review.
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Krug D, Banys-Paluchowski M, Brucker SY, Denkert C, Ditsch N, Fasching PA, Haidinger R, Harbeck N, Heil J, Huober J, Jackisch C, Janni W, Kolberg HC, Loibl S, Lüftner D, van Mackelenbergh M, Radosa JC, Reimer T, Welslau M, Würstlein R, Untch M, Budach W. Krug D, et al. Among authors: harbeck n. Strahlenther Onkol. 2024 Feb 23. doi: 10.1007/s00066-024-02209-7. Online ahead of print. Strahlenther Onkol. 2024. PMID: 38393398 Review.
519 results